Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
US Army
Daiichi Sankyo
Teva
Dow
Fuji
Johnson and Johnson
US Department of Justice

Generated: June 25, 2018

DrugPatentWatch Database Preview

TRI-SPRINTEC Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Tri-sprintec patents expire, and what generic alternatives are available?

Tri-sprintec is a drug marketed by Barr and is included in one NDA.

The generic ingredient in TRI-SPRINTEC is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
Summary for TRI-SPRINTEC
Drug patent expirations by year for TRI-SPRINTEC
Synonyms for TRI-SPRINTEC
18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17alpha)-, mixt. with (17alpha)-19 norpregna-1,3,5(10)-trien-20-yne-3,17-diol
79871-54-8
Cilest
Estarylla
Ethinyl estradiol and norgestimate
Ethinyl estradiol mixture with norgestimate
Ethinylestradiol-norgestimate mixt
LS-187956
LS-188020
Mili
Mono-Linyah
MonoNessa
Norgestimate / ethinyl estradiol
Norgestimate and ethinyl estradiol
Norgestimate mixture with ethinyl estradiol
Norgestimate-ethinylestradiol mixt
norgestimate, ethinyl estradiol drug combination
NORGESTIMATE; ETHINYL ESTRADIOL
Ortho Cylen
ORTHO Tri Cyclen
Ortho Tri Lo
Ortho Tri-cyclen 21
Ortho Tri-cyclen 28
Ortho Tri-cyclen Lo
Ortho Tri-Cylen
Pramino
SCHEMBL6382955
Tri Cyclen
Tri prevofem
Tri-Estarylla
Tri-Linyah
Tri-Lo-Estarylla
Tri-lo-sprintec
Tri-Mili
Tricilest
Tricileste
TriNessa
TriNessa-28

US Patents and Regulatory Information for TRI-SPRINTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr TRI-SPRINTEC ethinyl estradiol; norgestimate TABLET;ORAL-28 075808-001 Dec 29, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Federal Trade Commission
US Army
Healthtrust
Cipla
UBS
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.